Helen of Troy Limited (HELE) 10-Year Financial Performance & Capital Metrics

HELE • • Industrial / General

Consumer DefensiveHousehold ProductsSpecialty Tools & AccessoriesPersonal Care Tools

AboutHelen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty. The Home & Outdoor segment offers food preparation tools and gadgets, storage containers, and organization products; coffee makers, grinders, manual pour overs, and tea kettles; household cleaning products, shower organization, and bathroom accessories; feeding and drinking products, child seating products, cleaning tools, and nursery accessories; insulated water bottles, hydration packs, drinkware, mugs, food containers, lunch containers, insulated totes, soft coolers, and accessories; and technical and outdoor sports packs, travel packs, luggage, daypacks, and everyday packs. The Health & Wellness segment provides thermometers, blood pressure monitors, pulse oximeters, nasal aspirators, and humidifiers; faucet mount water-filtration systems and pitcher-based water filtration systems; and air purifiers, heaters, fans, and humidifiers. The Beauty segment offers grooming brushes, tools, and decorative hair accessories; and shampoos, liquid hair styling, and treatment and conditioning products, as well as hair appliances. The company sells its products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, grocery and specialty stores, beauty supply and e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers under the OXO, Good Grips, Hydro Flask, Soft Works, OXO tot, OXO Brew, OXO Strive, OXO Outdoor, Osprey, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Revlon, and Bed Head brands. Helen of Troy Limited was incorporated in 1968 and is headquartered in El Paso, Texas.Show more

Revenue $1.91B -4.9%
EBITDA $198M -36.6%
Net Income $124M -26.6%
EPS (Diluted) 5.37 -23.6%
Gross Margin 47.93% +1.3%
EBITDA Margin 10.37% -33.4%
Operating Margin 7.48% -42.4%
Net Margin 6.49% -22.9%
ROE 7.45% -30.9%
ROIC 4.33% -47.3%
Debt/Equity 0.57 +32.4%
Interest Coverage 2.75 -44.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 3.8% through buybacks
✓Trading at only 0.3x book value

✗Weaknesses

✗Weak momentum: RS Rating 16 (bottom 16%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.82%

5Y2.24%

3Y-4.98%

TTM-5.69%

Profit (Net Income) CAGR

10Y-0.58%

5Y-4.07%

3Y-17.92%

TTM-785.74%

EPS CAGR

10Y1.74%

5Y-2.26%

3Y-16.34%

TTM-797.37%

ROCE

10Y Avg11.47%

5Y Avg11.38%

3Y Avg8.43%

Latest5.65%

Peer Comparison

Personal Care Tools

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SPBSpectrum Brands Holdings, Inc.	1.48B	63.47	16.44	-5.23%	3.56%	5.23%	11.18%	0.34
RAYRaytech Holding Limited Ordinary Shares	9.11M	3.06	6.38	17.57%	12.49%	23.65%	68.31%
HELEHelen of Troy Limited	450.6M	19.53	3.64	-4.86%	-43.98%	-92.99%	18.45%	0.57
NWLNewell Brands Inc.	1.79B	4.28	-8.23	-6.77%	-0.33%	-0.89%	13.21%	1.86

Profit & Loss

	Feb 2016	Feb 2017	Feb 2018	Feb 2019	Feb 2020	Feb 2021	Feb 2022	Feb 2023	Feb 2024	Feb 2025
Sales/Revenue+	1.39B	1.4B	1.48B	1.56B	1.71B	2.1B	2.22B	2.07B	2.01B	1.91B
Revenue Growth %	-0.04%	0%	0.06%	0.06%	0.09%	0.23%	0.06%	-0.07%	-0.03%	-0.05%
Cost of Goods Sold+	866.84M	824.12M	867.65M	923.04M	972.97M	1.17B	1.27B	1.17B	1.06B	993.26M
COGS % of Revenue	0.62%	0.59%	0.59%	0.59%	0.57%	0.56%	0.57%	0.57%	0.53%	0.52%
Gross Profit+	525.73M	573.42M	611.2M	641.11M	734.47M	927.3M	953.19M	899.35M	948.66M	914.41M
Gross Margin %	0.38%	0.41%	0.41%	0.41%	0.43%	0.44%	0.43%	0.43%	0.47%	0.48%
Gross Profit Growth %	-0.12%	0.09%	0.07%	0.05%	0.15%	0.26%	0.03%	-0.06%	0.05%	-0.04%
Operating Expenses+	409.44M	403.75M	442.14M	441.73M	556.22M	645.81M	680.64M	687.56M	688.07M	771.66M
OpEx % of Revenue	0.29%	0.29%	0.3%	0.28%	0.33%	0.31%	0.31%	0.33%	0.34%	0.4%
Selling, General & Admin	368.01M	356.46M	374.58M	414.84M	484.5M	569.71M	611.03M	595.9M	621.74M	622.65M
SG&A % of Revenue	0.26%	0.26%	0.25%	0.27%	0.28%	0.27%	0.27%	0.29%	0.31%	0.33%
Research & Development	10M	11.8M	13.5M	13M	17.8M	53.4M	54M	47.8M	56.5M	53.9M
R&D % of Revenue	0.01%	0.01%	0.01%	0.01%	0.01%	0.03%	0.02%	0.02%	0.03%	0.03%
Other Operating Expenses	29.83M	35.49M	54.05M	13.89M	53.91M	22.7M	15.6M	43.86M	9.84M	95.11M
Operating Income+	116.29M	169.66M	169.06M	199.38M	178.25M	281.49M	272.55M	211.79M	260.59M	142.75M
Operating Margin %	0.08%	0.12%	0.11%	0.13%	0.1%	0.13%	0.12%	0.1%	0.13%	0.07%
Operating Income Growth %	-0.28%	0.46%	-0%	0.18%	-0.11%	0.58%	-0.03%	-0.22%	0.23%	-0.45%
EBITDA+	151.18M	205.84M	202.79M	229.31M	215.66M	319.21M	308.38M	256.47M	312.09M	197.8M
EBITDA Margin %	0.11%	0.15%	0.14%	0.15%	0.13%	0.15%	0.14%	0.12%	0.16%	0.1%
EBITDA Growth %	-0.25%	0.36%	-0.01%	0.13%	-0.06%	0.48%	-0.03%	-0.17%	0.22%	-0.37%
D&A (Non-Cash Add-back)	34.89M	36.17M	33.73M	29.93M	37.41M	37.72M	35.83M	44.68M	51.5M	55.05M
EBIT	146.13M	173.53M	193.06M	201.66M	220.36M	290.89M	275.05M	242.25M	249.82M	213.56M
Net Interest Income+	-10.59M	-14.45M	-13.97M	-11.72M	-12.71M	-12.62M	-12.84M	-40.75M	-53.06M	-51.92M
Interest Income	504K	0	0	0	0	0	0	0	0	0
Interest Expense	11.1M	14.86M	13.95M	11.72M	12.71M	12.62M	12.84M	40.75M	53.06M	51.92M
Other Income/Expense	-10.28M	-13.95M	-13.62M	-11.38M	-12.31M	-12.06M	-12.58M	-40.5M	-51.55M	-51.08M
Pretax Income+	106.01M	155.72M	155.44M	188M	165.94M	269.43M	259.97M	171.29M	209.04M	91.66M
Pretax Margin %	0.08%	0.11%	0.11%	0.12%	0.1%	0.13%	0.12%	0.08%	0.1%	0.05%
Income Tax+	18.59M	9.2M	26.56M	13.78M	13.61M	15.48M	36.2M	28.02M	40.45M	-32.09M
Effective Tax Rate %	0.95%	0.9%	0.29%	0.9%	0.92%	0.94%	0.86%	0.84%	0.81%	1.35%
Net Income+	101.23M	140.69M	44.45M	168.54M	152.33M	253.95M	223.76M	143.27M	168.59M	123.75M
Net Margin %	0.07%	0.1%	0.03%	0.11%	0.09%	0.12%	0.1%	0.07%	0.08%	0.06%
Net Income Growth %	-0.23%	0.39%	-0.68%	2.79%	-0.1%	0.67%	-0.12%	-0.36%	0.18%	-0.27%
Net Income (Continuing)	92.99M	144.31M	128.88M	174.22M	152.33M	253.95M	223.76M	143.27M	168.59M	123.75M
Discontinued Operations	8.24M	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	3.23	5.17	4.73	6.62	6.02	10.08	9.17	5.95	7.03	5.37
EPS Growth %	-0.29%	0.6%	-0.09%	0.4%	-0.09%	0.67%	-0.09%	-0.35%	0.18%	-0.24%
EPS (Basic)	3.29	5.24	4.76	6.68	6.06	10.16	9.27	5.98	7.06	5.38
Diluted Shares Outstanding	28.75M	27.89M	27.25M	26.3M	25.32M	25.2M	24.41M	24.09M	23.97M	23.07M
Basic Shares Outstanding	31.34M	27.21M	9.4M	25.46M	25.32M	25.19M	24.4M	24.08M	23.98M	23.04M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Feb 2016	Feb 2017	Feb 2018	Feb 2019	Feb 2020	Feb 2021	Feb 2022	Feb 2023	Feb 2024	Feb 2025
Total Current Assets+	772.72M	556.08M	555.31M	604.86M	682.84M	971.94M	1.08B	892.04M	843.92M	931.71M
Cash & Short-Term Investments	225.8M	23.09M	20.74M	11.87M	24.47M	45.12M	33.38M	29.07M	18.5M	18.87M
Cash Only	225.8M	23.09M	20.74M	11.87M	24.47M	45.12M	33.38M	29.07M	18.5M	18.87M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	217.9M	229.42M	275.91M	280.28M	348.02M	389.17M	463.05M	382.76M	402.41M	434.13M
Days Sales Outstanding	57.11	59.92	68.1	65.4	74.4	67.68	76.02	67.41	73.25	83.06
Inventory	301.61M	289.12M	251.51M	302.34M	256.31M	481.61M	557.99M	455.49M	396M	452.62M
Days Inventory Outstanding	127	128.05	105.81	119.55	96.15	150.05	160.35	141.69	136.82	166.33
Other Current Assets	0	14.4M	0	0	44.81M	39.87M	1.94M	24.72M	27.01M	26.1M
Total Non-Current Assets+	1.1B	1.26B	1.07B	1.04B	1.22B	1.29B	1.74B	2.02B	1.99B	2.2B
Property, Plant & Equipment	130.47M	134.94M	123.5M	130.34M	164.75M	169.07M	243.14M	390.54M	372.61M	365.09M
Fixed Asset Turnover	10.67x	10.36x	11.97x	12.00x	10.36x	12.41x	9.14x	5.31x	5.38x	5.23x
Goodwill	583M	698.93M	602.32M	602.32M	739.9M	739.9M	948.87M	1.07B	1.07B	1.18B
Intangible Assets	375.75M	419.49M	302.92M	291.53M	300.95M	357.26M	537.85M	553.88M	536.7M	566.76M
Long-Term Investments	0	0	2.2M	218K	23K	33K	2.92M	1.82M	1.19M	302K
Other Non-Current Assets	6.09M	1.71M	18.42M	12.28M	784K	3.54M	4.97M	6.17M	13.82M	17.66M
Total Assets+	1.87B	1.81B	1.62B	1.65B	1.9B	2.26B	2.82B	2.91B	2.84B	3.13B
Asset Turnover	0.74x	0.77x	0.91x	0.95x	0.90x	0.93x	0.79x	0.71x	0.71x	0.61x
Asset Growth %	0.13%	-0.03%	-0.11%	0.02%	0.15%	0.19%	0.25%	0.03%	-0.03%	0.1%
Total Current Liabilities+	268.76M	289.37M	297.09M	312.03M	338.9M	614.89M	602.69M	412.16M	450.81M	466.26M
Accounts Payable	103.71M	105.65M	129.34M	143.56M	152.67M	334.81M	308.18M	190.6M	245.35M	269.4M
Days Payables Outstanding	43.67	46.79	54.41	56.77	57.27	104.31	88.56	59.29	84.77	99
Short-Term Debt	22.64M	24.4M	1.88M	1.88M	1.88M	1.88M	1.88M	6.06M	6.25M	9.38M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	6.36M	36.35M	34.88M	47.25M	45.03M	65.01M	58.23M	54.03M	56.47M	62.14M
Current Ratio	2.88x	1.92x	1.87x	1.94x	2.01x	1.58x	1.80x	2.16x	1.87x	2.00x
Quick Ratio	1.75x	0.92x	1.02x	0.97x	1.26x	0.80x	0.87x	1.06x	0.99x	1.03x
Cash Conversion Cycle	140.44	141.18	119.49	128.19	113.28	113.42	147.81	149.81	125.31	150.39
Total Non-Current Liabilities+	670.84M	502.96M	309.77M	340.87M	403.26M	409.25M	893.42M	1.01B	750.37M	982.38M
Long-Term Debt	597.27M	461.21M	287.99M	318.9M	337.42M	341.75M	811.33M	928.35M	659.42M	907.52M
Capital Lease Obligations	0	0	0	0	40.86M	38.35M	43.74M	42.67M	37.26M	39.95M
Deferred Tax Liabilities	44.12M	20.09M	7.1M	5.75M	4.22M	5.74M	21.58M	28.05M	41.25M	29.28M
Other Non-Current Liabilities	26.61M	21.66M	14.69M	16.22M	20.76M	23.42M	16.76M	13.68M	12.43M	5.63M
Total Liabilities	939.6M	792.33M	606.86M	652.9M	742.16M	1.02B	1.5B	1.42B	1.2B	1.45B
Total Debt+	619.91M	485.62M	289.87M	320.78M	380.17M	381.98M	856.96M	977.08M	702.93M	956.84M
Net Debt	394.11M	461.77M	269.13M	308.91M	355.7M	336.86M	823.58M	948.01M	684.43M	937.98M
Debt / Equity	0.67x	0.48x	0.29x	0.32x	0.33x	0.31x	0.65x	0.66x	0.43x	0.57x
Debt / EBITDA	4.10x	2.36x	1.43x	1.40x	1.76x	1.20x	2.78x	3.81x	2.25x	4.84x
Net Debt / EBITDA	2.61x	2.24x	1.33x	1.35x	1.65x	1.06x	2.67x	3.70x	2.19x	4.74x
Interest Coverage	10.48x	11.42x	12.12x	17.01x	14.03x	22.31x	21.22x	5.20x	4.91x	2.75x
Total Equity+	930.04M	1.02B	1.01B	996.64M	1.16B	1.24B	1.33B	1.49B	1.64B	1.68B
Equity Growth %	0.03%	0.1%	-0.01%	-0.02%	0.17%	0.07%	0.07%	0.12%	0.1%	0.03%
Book Value per Share	32.35	36.60	37.22	37.89	45.88	49.19	54.38	61.80	68.31	72.99
Total Shareholders' Equity	930.04M	1.02B	1.01B	996.64M	1.16B	1.24B	1.33B	1.49B	1.64B	1.68B
Common Stock	2.77M	2.7M	2.66M	2.5M	2.52M	2.44M	2.38M	2.4M	2.38M	2.29M
Retained Earnings	728.53M	798.13M	780.49M	746.37M	898.17M	965.17M	1.02B	1.16B	1.28B	1.31B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	665K	1.17M	631K	1.19M	-7M	-11.66M	202K	4.95M	2.1M	2.28M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Feb 2016	Feb 2017	Feb 2018	Feb 2019	Feb 2020	Feb 2021	Feb 2022	Feb 2023	Feb 2024	Feb 2025
Cash from Operations+	185.26M	228.5M	224.21M	195.3M	271.29M	314.11M	140.82M	208.24M	306.07M	113.21M
Operating CF Margin %	0.13%	0.16%	0.15%	0.12%	0.16%	0.15%	0.06%	0.1%	0.15%	0.06%
Operating CF Growth %	0.04%	0.23%	-0.02%	-0.13%	0.39%	0.16%	-0.55%	0.48%	0.47%	-0.63%
Net Income	101.23M	140.69M	128.88M	174.22M	152.33M	253.95M	223.76M	143.27M	168.59M	123.75M
Depreciation & Amortization	42.75M	44.34M	33.73M	29.93M	37.41M	37.72M	35.83M	44.68M	51.5M	55.05M
Stock-Based Compensation	8.48M	15.5M	15.05M	22.05M	22.93M	26.42M	34.62M	26.75M	33.87M	21.38M
Deferred Taxes	-464K	-7.25M	21.26M	7.64M	-5.7M	-4.4M	-8.87M	-2.24M	13.21M	0
Other Non-Cash Items	24.91M	16.12M	23.33M	-3.69M	45.02M	18.65M	8.12M	11.34M	-14.63M	-12.34M
Working Capital Changes	8.36M	19.1M	1.95M	-34.84M	19.3M	-18.23M	-152.64M	-15.57M	53.52M	-74.63M
Change in Receivables	-3.6M	-6.83M	-34.38M	-5.78M	-57.42M	-38.15M	-66.83M	83.62M	-18.67M	-23.08M
Change in Inventory	-17.61M	18.97M	29.37M	-50.83M	45.48M	-220.82M	-45.91M	110.3M	58.19M	-40.6M
Change in Payables	7.04M	5.8M	23.69M	14.22M	7.17M	175.78M	-43.74M	-115.93M	54.4M	20.46M
Cash from Investing+	-63.75M	-229.85M	35.63M	-25.25M	-273.62M	-98.67M	-438.91M	-319.33M	5.45M	-263.09M
Capital Expenditures	-20.6M	-20.62M	-13.61M	-26.39M	-17.76M	-98.67M	-78.04M	-174.86M	-36.64M	-30.07M
CapEx % of Revenue	0.01%	0.01%	0.01%	0.02%	0.01%	0.05%	0.04%	0.08%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	7K	32K	49.23M	0	3K	0	5.3M	69K	49.46M	-1.75M
Cash from Financing+	91.99M	-201.36M	-262.19M	-178.92M	14.92M	-194.78M	286.35M	106.78M	-322.09M	150.25M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-12M	-595K	0	0	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	164.66M	207.88M	210.6M	168.92M	253.53M	215.44M	62.78M	33.38M	269.42M	83.14M
FCF Margin %	0.12%	0.15%	0.14%	0.11%	0.15%	0.1%	0.03%	0.02%	0.13%	0.04%
FCF Growth %	-0.04%	0.26%	0.01%	-0.2%	0.5%	-0.15%	-0.71%	-0.47%	7.07%	-0.69%
FCF per Share	5.73	7.45	7.73	6.42	10.01	8.55	2.57	1.39	11.24	3.60
FCF Conversion (FCF/Net Income)	1.83x	1.62x	5.04x	1.16x	1.78x	1.24x	0.63x	1.45x	1.82x	0.91x
Interest Paid	13.99M	9.98M	13.54M	11.29M	12.78M	11.64M	11.69M	43.69M	52.54M	50.15M
Taxes Paid	16.59M	15.95M	6.08M	4.28M	23.28M	19.69M	22.83M	37.08M	28.86M	40.84M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	11.04%	14.42%	4.37%	16.76%	14.12%	21.15%	17.44%	10.18%	10.79%	7.45%
Return on Invested Capital (ROIC)	6.58%	9.06%	9.17%	11.55%	9.47%	13.65%	10.97%	6.92%	8.21%	4.33%
Gross Margin	37.75%	41.03%	41.33%	40.99%	43.02%	44.18%	42.87%	43.39%	47.31%	47.93%
Net Margin	7.27%	10.07%	3.01%	10.78%	8.92%	12.1%	10.06%	6.91%	8.41%	6.49%
Debt / Equity	0.67x	0.48x	0.29x	0.32x	0.33x	0.31x	0.65x	0.66x	0.43x	0.57x
Interest Coverage	10.48x	11.42x	12.12x	17.01x	14.03x	22.31x	21.22x	5.20x	4.91x	2.75x
FCF Conversion	1.83x	1.62x	5.04x	1.16x	1.78x	1.24x	0.63x	1.45x	1.82x	0.91x
Revenue Growth	-3.64%	0.36%	5.82%	5.77%	9.16%	22.92%	5.93%	-6.78%	-3.26%	-4.86%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Beauty & Wellness	-	-	-	-	-	-	-	1.16B	1.09B	1B
Beauty & Wellness Growth	-	-	-	-	-	-	-	-	-5.90%	-8.02%
Home & Outdoor	-	-	-	-	-	-	865.84M	915.68M	916.38M	906.33M
Home & Outdoor Growth	-	-	-	-	-	-	-	5.76%	0.08%	-1.10%
Health & Wellness	-	-	-	-	-	-	777.08M	-	-	-
Health & Wellness Growth	-	-	-	-	-	-	-	-	-	-
Beauty	439.18M	355.78M	349.32M	345.13M	381.07M	481.25M	580.43M	-	-	-
Beauty Growth	-	-18.99%	-1.81%	-1.20%	10.41%	26.29%	20.61%	-	-	-
Healthcare Home Environment	642.74M	632.77M	682.61M	695.22M	685.4M	890.19M	-	-	-	-
Healthcare Home Environment Growth	-	-1.55%	7.88%	1.85%	-1.41%	29.88%	-	-	-	-
Housewares	310.66M	418.13M	457.82M	523.81M	640.97M	727.35M	-	-	-	-
Housewares Growth	-	34.59%	9.49%	14.41%	22.37%	13.48%	-	-	-	-
Nutritional Supplements	153.13M	130.54M	-	-	-	-	-	-	-	-
Nutritional Supplements Growth	-	-14.75%	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
UNITED STATES	-	-	-	1.22B	1.36B	1.67B	1.74B	1.54B	1.48B	1.36B
UNITED STATES Growth	-	-	-	-	11.09%	22.76%	4.31%	-11.46%	-3.95%	-8.21%
EMEA	-	-	-	143.02M	138.86M	183.4M	214.58M	268.15M	284.43M	294.95M
EMEA Growth	-	-	-	-	-2.91%	32.08%	17.00%	24.96%	6.07%	3.70%
Asia Pacific	-	-	-	90.07M	99.38M	118M	109.75M	115.63M	116.16M	125.43M
Asia Pacific Growth	-	-	-	-	10.33%	18.74%	-6.99%	5.35%	0.46%	7.98%
CANADA	-	-	-	66.86M	71.42M	92.15M	101.62M	108.42M	82.12M	82.5M
CANADA Growth	-	-	-	-	6.82%	29.03%	10.27%	6.69%	-24.25%	0.46%
Latin America	-	-	-	42.39M	40.43M	38.93M	59.31M	41.62M	44.2M	48.03M
Latin America Growth	-	-	-	-	-4.62%	-3.73%	52.35%	-29.82%	6.21%	8.67%
Segment Geographical International Outside U S	312.24M	295.57M	320.86M	-	-	-	-	-	-	-
Segment Geographical International Outside U S Growth	-	-5.34%	8.56%	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Helen of Troy Limited (HELE) has a price-to-earnings (P/E) ratio of 3.6x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Helen of Troy Limited (HELE) reported $1.80B in revenue for fiscal year 2025. This represents a 53% increase from $1.18B in 2012.

Helen of Troy Limited (HELE) saw revenue decline by 4.9% over the past year.

Helen of Troy Limited (HELE) reported a net loss of $792.5M for fiscal year 2025.

Dividend & Returns

Helen of Troy Limited (HELE) has a return on equity (ROE) of 7.5%. This is below average, suggesting room for improvement.

Helen of Troy Limited (HELE) generated $80.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...